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ABSTRACT 
 
 
The SYRMEP (SYnchrotron Radiation for MEdical Physics) beamline at Elettra is performing the 
first mammography study on human patients using free-space propagation phase contrast imaging. 
The stricter spatial resolution requirements of this method currently force the use of conventional 
films or specialized computed radiography (CR) systems. This also prevents the implementation of 
three-dimensional (3D) approaches. This paper explores the use of an X-ray detector based on 
complementary metal-oxide-semiconductor (CMOS) active pixel sensor (APS) technology as a 
possible alternative, for acquisitions both in planar and tomosynthesis geometry. 
Results indicate higher quality of the images acquired with the synchrotron set-up in both 
geometries.  This improvement can be partly ascribed to the use of parallel, collimated and 
monochromatic synchrotron radiation (resulting in scatter rejection, no penumbra-induced blurring 
and optimized X-ray energy), and partly to phase contrast effects. Even though the pixel size of the 
used detector is still too large – and thus suboptimal – for free-space propagation phase contrast 
imaging, a degree of phase-induced edge enhancement can clearly be observed in the images.  
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I. INTRODUCTION 
 
Digital X-ray detectors based on complementary metal-oxide-semiconductor (CMOS) active pixel 
sensor (APS) technology have been recently introduced in mammographic imaging, especially in 
relatively new fields such as digital breast tomosynthesis (DBT) [1, 2]. Considering the difficulties 
involved in a full three-dimensional (3D) computed tomography (CT) acquisition of the female 
breast, partial view tomography performed in tomosynthesis conditions offers a valuable alternative. 
Although full tomographic slices are not reconstructed, DBT allows “slicing” the sample volume in 
separate layers along the main x-ray propagation direction, thus solving to a good extent the 
“structural noise” problem caused by overlying structures [3]. At the same time, it offers sufficiently 
fast acquisitions and good dose control. 
Another important recent innovation in X-ray imaging is the exploitation of phase effects [4]. 
Although this is not yet available in clinical practice, the Trieste medical physics group from the 
SYRMEP beamline of the Elettra synchrotron is carrying out in a pilot study on human patients 
using synchrotron radiation [5-7]. Among different phase-sensitive techniques, this study uses free 
space propagation (FSP). This provides edge enhancement of the imaged samples leading to a 
significant improvement in detail visibility, enabling earlier lesion detection [8]. The FSP 
implementation is the simplest and was thus considered the most suitable to a first in vivo translation 
on human patients. If the source is sufficiently coherent, optimizing the distance between sample and 
detector is sufficient to become sensitive to phase effects (alongside absorption).  
 
Due to the demanding requirements that FSP phase contrast imaging (PCI) imposes on the detector 
resolution, so far the program has been based on mammography screen-film (SF) systems, and the 
first tests with high-resolution storage phosphor (also termed CR) systems have started only recently. 
This is suboptimal in many ways, especially as far as films are concerned, as only analogic images 
are obtained, with limited dynamic range and contrast resolution. An improvement is expected 
thanks to the transition to storage phosphor systems, however real-time imaging will still not be 
available, and 3D or quasi-3D approaches consequently impossible. We propose here a possible 
solution based on the use of a large area CMOS-based X-ray detector developed by Dexela Ltd (a 
PerkinElmer company).  
 
II. MATERIALS AND METHODS 
 
II.A. Free space propagation phase contrast imaging 
 
FSP PCI is the simplest among phase contrast methods in terms of practical implementation. An 
object is irradiated by a spatially coherent X-ray beam, and an X-ray detector is placed at a distance 
 3 
from the object. No additional optical elements are required, as the edge enhancement is due to the 
interference between the components of the X-ray wave front passing through different parts of the 
sample, consequently suffering different phase shifts. This can be described by means of near-field 
(Fresnel) diffraction theory. The intensity distribution at a distance z from the sample is given by: 
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where   r

 is the phase shift caused by the object. The diffraction pattern must then be convolved 
with the detector point spread function (PSF) [9], which means it becomes increasingly smeared as 
the detector resolution is decreased. This leads to a reduction of the intensity of the interference 
fringes, i.e. the phase contrast. Formally a convolution with the (re-scaled) source size should also be 
performed, but, in the case discussed here (small and distant bending magnet synchrotron source and 
detector with 75 m pixel pitch), this is negligible with respect to the detector resolution. 
 
II.B. Prototype detector developed by Dexela Ltd (a PerkinElmer company) 
 
The Dexela 2923 CMOS X-ray detector is based on an APS architecture. In a typical CMOS sensor 
the photodiode is reset while the charge is accumulated and the charge value is then read out. The 
APS technology indicates the process of buffering and/or amplification of the signal by a source 
follower (SF) transistor located in each pixel. This allows better SNR and speeds up the readout 
process, as the signal is transferred onto a common readout bus as voltage rather than charge. A 
detailed description of the detector can be found elsewhere [10]. The active area of the detector used 
for the experiments was 3888 x 3072 pixels, i.e. 29 cm x 23 cm. The detector pixel pitch is 75μm. 
The maximum pixel resolution (i.e. no binning) was used, which translates into a maximum readout 
rate of 26 frames per second. The X-ray performance evaluation of the detector has been tested with 
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monochromatic synchrotron radiation in the mammographic energy range and reported in [11]. The 
authors measured the detective quantum efficiency (DQE), which ranges from 0.79 to 0.85 at a 
frequency of 0.5 lp/mm and at 17 keV and 0.75 to 0.79 at 20 keV. The spatial resolution at 17 keV 
expressed in 50% MTF is 2.8 lp/mm.  
 
II.C. Experimental conditions 
 
 
The synchrotron experiments were carried out at the SYRMEP beamline of the Elettra synchrotron 
radiation facility (Trieste, Italy). Figure 1a shows a schematic drawing of the synchrotron setup. The 
X-ray beam generated by one of the bending magnets is monochromatized by a double-bounce 
Si(111) crystal, which enables selecting the required energy with a bandwidth of approximately 
0.2% in the range is 8.5-35 keV. Our experiments were performed at 21 keV. Dosimetry 
measurements were obtained with a ionization chamber placed at about 21 m from the source. The 
CMOS X-ray detector was mounted on a translation stage at a source-to-detector distance of about 
23 m. Tungsten (W) slits were used to limit the beam to a cross-section of 206 mm x 3 mm on the 
detector surface.  During the acquisition, the detector was moved vertically with a speed of 15 mm/s 
over a range covering the entire sample area. The sample was also simultaneously scanned, at a 
slightly reduced speed to preserve the angular velocity with respect to the source thus avoiding 
image distortions. 
 
 (a) 
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(b)  (c) 
Figure 1 Elettra SYRMEP beam-line experimental setup. Figure adopted from (http://www.elettra.trieste.it), 
modified and mammography facility at SYRMEP beamline: patient support (b) and positioning of the biopsy 
phantom (c) 
 
In the tomosynthesis experiments at the synchrotron, a rotation stage with an angular resolution of 
10-3 degrees was used. The biopsy phantom was placed in the patient support (see Figure 1c) used 
for the in vivo procedures. A tomosynthesis scanning method was adopted in which the phantom was 
rotated (rigidly with the patient bed) about its central position within a non-equiangular range of 40°, 
while the X-ray source and the detector were kept stationary. A total of 13 projections were 
collected.  
The «standard» tomosynthesis scanning was obtained with the Giotto DBT system, details of which 
are given in Table 1 The phantom was placed at a distance of 66.6 cm from the source. A set of 13 
projections was acquired over a not equiangular range of 40°.  
The planar imaging of the ACR phantom was performed with the Senographe Essential (GE) clinical 
mammography system. 
 
Table 1 Experimental conditions. MGD refers to Mean Glandular Dose and ESAK refers to Entrance Surface Air 
Kerma. 
  Synchrotron imaging Conventional imaging 
  Planar tomosynthesis Planar Tomosynthesis 
energy (mean 
energy) 
21 keV 19 keV 28 kVp (18.4 keV) 27 kVp (19.7 keV) 
detector CMOS APS CMOS APS a-Si TFT a-Se TFT 
pixel size 75 μm 75 μm 100 μm 85 μm 
anode/filter NA NA Rh/Rh W/Ag 
projections 1 13 1 13 
phantom ACR Biopsy Biopsy, ACR Biopsy 
ESAK 2.15 mGy 1.21 mGy  N/A 
MGD 0.9 mGy 
0.3 mGy (single 
projection) 
1.1 mGy 
 
0.2 mGy (single 
projection) 
4.2 mGy (whole 
TS scan) 
2.7 mGy (whole TS 
scan) 
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All images were gain and offset corrected to remove pixel-to-pixel variations and non-uniformities 
in the irradiation profile. The tomosynthesis slices were reconstructed with an iterative algorithm 
provided by Dexela Ltd, based on the Separable Paraboidal Surrogates (SPS) algorithm. More 
details on the reconstruction method can be found in [12]. 
 
For planar imaging we used a 4.5 cm thick  ACR mammography accreditation phantom (Figure 2a), 
which contains test objects placed in a wax block. The details included in the wax layer simulate 
typical breast pathologies: fibres, microcalcifications and tumour masses.  
(a) (b) 
Figure 2 American College of Radiology (ACR) accreditation phantom (a) containing six fibres (F1 to F6) with 
the thickness varying between 1.56 mm and 0.4 mm, five groups of microcalcification specks (S1 to S5) with the 
diameter between 0.54 mm (S1) and 0.16 mm (S5) and five tumour-like masses (M1 to M5) with the diameter of 
between 2 mm and 0.16 mm. (b) Stereotactic biopsy phantom placed between compression pads. 
 
A Stereotactic Needle Biopsy Phantom (Figure 2b) was used for both planar and tomosynthesis 
imaging. The phantom is a standard tool for quality assurance in stereotactic systems. The phantom 
is shaped as to represent a partially compressed breast with a standard thickness of 4.5 cm. A 
number of randomly placed solid masses in the range of 3 to 6 mm simulate tumour masses. Two 
calcifications clusters are positioned in a middle plane of the phantom. The diameters of the 
calcifications range from 300 μm to 350 μm. 
The mean glandular dose (MGD) delivered to the sample was calculated based on the European [13] 
and IAEA [14] protocols for Dosimetry in conventional mammography. According to [15], the 
MGD can be calculated as: 
 
gcsKMGD a             (6) 
 
where 
aK  corresponds to the air kerma measured at the surface of the breast, g and c are the 
conversion factors that correspond to the glandularity level of the breast (in this case g corresponds 
to 50% glandularity of the breast while c allows for different levels of glandularity); s is the 
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conversion factor used to account for different x-ray spectra. In this study, the normalized glandular 
dose coefficients for monochromatic x-rays were taken from [16]. 
The above definition of MGD can be extended to a tomosynthesis geometry by adding two further 
correction factors: t-factors and T-factors [17]. The t-factors correspond to a single projection at a 
given angle   and depend upon the x-ray spectra, breast sizes and glandularities, while the T-factors 
take into account the complete tomosynthesis scan and depend on the choice of projection angles 
and weights per projection. These factors have primarily a geometrical origin for both the clinical 
and the synchrotron setups.  According to [17], the correction factor T for an angular range of -20° to 
20° and a breast thickness of 40 mm would be 0.973, giving a difference of 2.7 % on the MGD. This 
difference would thus be even smaller for the angular range used in this work, and was therefore 
neglected. It should also be noted that the clinical tomosynthesis was performed at higher x-ray tube 
voltage than the usual clinical practice (and delivering higher dose to the phantom) to match the 
synchrotron values.  
 
The quantitative analysis of the images was based on the contrast-to-noise ratio (CNR), a commonly 
used parameter for the assessment of the image quality. In conventional absorption-based imaging, 
the ABSCNR  is calculated as the difference between the intensity value of a feature featureI and the 
intensity value of the background bgI , divided by the standard deviation of the intensity values of the 
background bg :   bgbgfeatureABS IICNR / . Phase contrast images are characterized by intense 
positive and negative peaks; Hence, the contrast is redefined on the basis of the difference between 
maximum and minimum peak intensities (C = ( maxI  - minI )/Ibg) [18]; the CNR is consequently  
redefined as: 
 
 
bg
PC
II
CNR

minmax              (7) 
 
 
III. RESULTS AND DISCUSSIONS 
 
III.A. Planar imaging 
 
Figure 3 shows a comparison between conventional and synchrotron radiation planar images of 
different regions of interest (ROIs) within the ACR phantom. Since the acceptable clinical level of 
MGD delivered in two projections to a breast equivalent thickness of 4.5 cm is 2 mGy [19], we kept 
the MGD close to 1 mGy per image in both synchrotron and clinical experiments. The specks with a 
diameter equal and larger than 320 μm were easily detectable in both conventional and synchrotron 
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images. The specks with a diameter of 160 μm were detectable only in the synchrotron images. The 
lower limit of the thickness of fibres for the conventional system was 750 μm, while fibre 
thicknesses down to 400 μm were detected in the synchrotron images. Phase contrast effects are 
visible at the edges of the fibres as dark and bright fringes. Significant advantages were observed 
also on the imaging of the masses, as details with a diameter of 160 μm were detectable in 
synchrotron images, while the conventional system was limited to masses with a diameter of 500 
μm.  
Figure 4 shows a planar image of a region of about 600 x 1000 pixels of the biopsy breast phantom 
(corresponding to approximately half the image). A superior contrast of the tumour masses and 
calcifications can be observed in the synchrotron image compared to the conventional one. In the 
synchrotron images, phase contrast effects are visible at the boundaries of the tumour-like masses as 
dark and bright fringes on the immediate inside and outside of the mass, respectively. 
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 (a) 
 
 
 
 (b) 
Figure 3 Images of an ACR phantom with a selected ROI (left) obtained with a) 
a clinical system and b) using synchrotron radiation 
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a)  b)  
Figure 4 Single projection image of an ROI in the biopsy phantom obtained with (a) clinical tomosynthesis system 
and (b) synchrotron radiation. The gradient visible in both images (e.g. bottom right corner) has probably been 
caused by not-ideal gain and offset corrections.  
  
 
III.B. Digital Tomosynthesis of the biopsy breast phantom 
 
The MGD delivered to the sample during one tomosynthesis projection at the synchrotron was 
estimated to be 0.3 mGy, while it was 0.2 mGy for the conventional tomosynthesis image. The MGD 
of the entire tomosynthesis scan was therefore 4.2 mGy and 2.7 mGy for the synchrotron and 
conventional acquisitions, respectively. For comparison, in DBT a typical MGD for a 4.5 cm thick 
phantom ranges from 1.9 mGy to 2.1 mGy, depending on the system [20]. Three reconstructed slices 
are presented in Figure 5, which shows images obtained with both the clinical system and 
synchrotron radiation. The reconstruction planes are 0.5 mm thick, and cover the entire phantom 
area (i.e. 20 cm x 15 cm). Ten iteration steps were used in the reconstruction. Out of plane objects 
cause blurring artefacts, while the edges of the objects in the plane of focus are crisp and exhibit 
phase contrast edge enhancement. 
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 (a)  (b)  (c) 
 (d)  (e)  (f) 
Figure 5 Selected reconstructions of the biopsy phantom obtained with the clinical tomosynthesis system (a-c) and 
using synchrotron radiation (d-f). Different features are in focus when slicing through the reconstructed volume 
from left to right. The objects that are not in the plane of focus appear as multiple replicas causing blurring 
artefacts. 
 
 Figure 6 shows a comparison between the signal obtained with the clinical system and synchrotron 
radiation for a single projection ROI at angle 0º containing a tumour-like mass. Although the phase 
contrast signal is weak (due to the excessively large pixel size washing out the phase contrast 
fringes), it can be still clearly observed at the boundaries of the detail in the synchrotron images (see 
arrows in Figure 6). The image contrast is two times larger in the synchrotron images than in those 
obtained with a clinical system (see Figure 8). Likewise, a significant increase in the CNR can be 
seen for the synchrotron images. It should be noted however that the higher contrast in the phase 
contrast images might be partially caused by the reconstruction algorithm, which was primarily 
designed for the absorption-based images. 
Figure 7 shows an ROI of the reconstructed tomosynthesis image of the same tumour-like object. 
While the images obtained with synchrotron radiation preserve the phase contrast signal, this is 
missing from the image taken with the clinical system (see the vertical profile plot in Figure 7c). The 
bright fringes visible in the clinical image are not due to phase effects as they only appear on the 
sides of the objects and not all around it. These artefacts are due to the air gaps between the details 
and the phantom gel, and are intensified by the reconstruction algorithm. If these are ignored, both 
image contrast and CNR (shown in Figure 10) are superior for the images obtained with the 
synchrotron radiation compared to those taken with a clinical system.  
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(a)  (b)  (c) 
(d)  (e)  (f) 
 
Figure 6 Single projections at 0º (a, d) and corresponding horizontal (b, e) and vertical (c, f) profile plots obtained 
with a conventional TS system (a, b, c) and with synchrotron radiation (d, e, f). The arrows show the signal build-
up due to the phase contrast effects. 
 
(a)  (b)  (c) 
(d)  (e)  (f) 
 
Figure 7 Reconstructions (a, d) and corresponding horizontal (b, e) and vertical (c, f) profile plots obtained with a 
conventional TS system (a, b, c) and with synchrotron radiation (d, e, f). The build-up of the signal indicated by 
the arrows is only present in the synchrotron images and is caused by the phase contrast effects.  
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 (a) 
 (b) 
Figure 8 Contrast and CNR calculated for the clinical and synchrotron projection and reconstructed image from 
Figure 6 and Figure 7. 
  
 
IV. CONCLUSIONS 
 
The purpose of this study was to test the imaging performance of a novel CMOS APS X-ray detector 
at the only in vivo mammography synchrotron beamline, and compare the obtained images with 
those acquired with a clinical system. A considerably higher image contrast was obtained at the 
synchrotron for both planar and tomosynthesis images with respect to conventional mammograms 
and reconstructed tomosynthesis slices. The reason for this is twofold. First, the image contrast of 
the synchrotron images is enhanced thanks to the superior characteristics of the synchrotron beam 
(e.g. monochromaticity), as well as scatter reduction due to air gap and possibly tight beam 
collimation. Secondly, and possibly most importantly, image improvement originates from the edge 
enhancement induced by FSP phase contrast fringes.  Despite the blurring effect due to a relatively 
large pixel size of 75 m, these were still clearly appreciable in practically all synchrotron images. 
This is promising both in terms of replacing the current screen-film systems and storage phosphor 
systems used by the in vivo study in Trieste, and for future developments regarding the translation of 
phase contrast methods into clinical practice. Clearly, should detectors with comparable performance 
and smaller pixel size become commercially available in the near future, even stronger image 
enhancements due to phase effects would be expected. 
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